HIGH-DOSE CYTARABINE FOR THE TREATMENT OF BLASTIC PHASE CHRONIC MYELOGENOUS LEUKEMIA

被引：0
|
作者：
HERZIG, RH
PHILLIPS, GL
LAZARUS, HM
WOLFF, SN
HERZIG, GP
机构：
[1] CASE WESTERN RESERVE UNIV,DEPT MED,CLEVELAND,OH 44106
[2] WASHINGTON UNIV,DEPT MED,ST LOUIS,MO 63130
[3] VANDERBILT UNIV,DEPT MED,NASHVILLE,TN 37240
来源：
CANCER TREATMENT REPORTS | 1985年 / 69卷 / 7-8期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：881 / 883
页数：3
相关论文
共 50 条
  • [1] TREATMENT OF THE BLASTIC PHASE OF CHRONIC MYELOGENOUS LEUKEMIA WITH HIGH-DOSE CYTOSINE-ARABINOSIDE
    ERNST, TJ
    ROSENTHAL, DS
    GRIFFIN, JD
    CANELLOS, GP
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1988, 11 (06): : 623 - 626
  • [2] TREATMENT OF THE BLASTIC PHASE OF CHRONIC MYELOGENOUS LEUKEMIA WITH MITOXANTRONE AND HIGH-DOSE CYTOSINE-ARABINOSIDE
    KANTARJIAN, HM
    WALTERS, RS
    KEATING, MJ
    TALPAZ, M
    ANDERSSON, B
    BERAN, M
    MCCREDIE, KB
    FREIREICH, EJ
    [J]. CANCER, 1988, 62 (04) : 672 - 676
  • [3] PRELIMINARY EXPERIENCE WITH SHORT COURSE HIGH-DOSE MITOXANTRONE IN COMBINATION WITH HIGH-DOSE CYTARABINE IN PATIENTS WITH ACUTE-LEUKEMIA AND BLASTIC PHASE OF CHRONIC MYELOGENOUS LEUKEMIA
    FELDMAN, EJ
    BIGUZZI, S
    AHMED, T
    MITTELMAN, A
    PUCCIO, CA
    BASKIND, P
    ARLIN, ZA
    [J]. LEUKEMIA & LYMPHOMA, 1990, 3 (03) : 209 - 211
  • [4] HIGH-DOSE CYTARABINE IN ACUTE MYELOGENOUS LEUKEMIA
    ZITTOUN, R
    [J]. BONE MARROW TRANSPLANTATION, 1989, 4 : 38 - 42
  • [5] TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA IN ACCELERATED AND BLASTIC PHASES WITH DAUNORUBICIN, HIGH-DOSE CYTARABINE, AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR
    KANTARJIAN, HM
    TALPAZ, M
    KONTOYIANNIS, D
    GUTTERMAN, J
    KEATING, MJ
    ESTEY, EH
    OBRIEN, S
    RIOS, MB
    BERAN, M
    DEISSEROTH, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (03) : 398 - 405
  • [6] Etoposide, intermediate-dose cytarabine and carboplatin (VAC): A combination therapy for the blastic phase of chronic myelogenous leukemia
    Montefusco, E
    Petti, MC
    Alimena, G
    Latagliata, R
    Celesti, F
    Capria, S
    Amadori, S
    Avvisati, G
    Mandelli, F
    [J]. ANNALS OF ONCOLOGY, 1997, 8 (02) : 175 - 179
  • [7] Blastic phase of chronic myelogenous leukemia
    Esfahani M.K.
    Morris E.L.
    Dutcher J.P.
    [J]. Current Treatment Options in Oncology, 2006, 7 (3) : 189 - 199
  • [8] A phase I/II study of high-dose cytarabine and topotecan for the treatment of resistant acute myelogenous leukemia.
    Schiller, G
    Hepner, A
    Lee, M
    Sawyers, C
    Paquette, R
    Territo, M
    [J]. BLOOD, 1998, 92 (10) : 218B - 218B
  • [9] PHASE-II STUDY OF AMSACRINE AND HIGH-DOSE CYTARABINE FOR RESISTANT ACUTE MYELOGENOUS LEUKEMIA
    DECKER, RW
    HO, WG
    CHAMPLIN, RE
    [J]. CANCER TREATMENT REPORTS, 1987, 71 (09): : 881 - 882
  • [10] TREATMENT OF BLASTIC PHASE CHRONIC MYELOGENOUS LEUKEMIA WITH MEGA-DOSE METHYL-PREDNISOLONE
    BOLAMAN, Z
    BILGIR, O
    ERTOP, S
    YENICE, N
    YILMAZ, E
    MUFTUOGLU, E
    [J]. JOURNAL OF CHEMOTHERAPY, 1993, 5 : 670 - 671
12345